Document Detail


The value of dynamic MRI studies in parotid tumors.
MedLine Citation:
PMID:  17502260     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
RATIONALE AND OBJECTIVES: To evaluate the ability of dynamic contrast-enhanced magnetic resonance imaging (MRI) to differentiate several tumor entities of the parotid gland in a prospective clinical trial. MATERIALS AND METHODS: A total of 112 patients with parotid tumors were examined with dynamic contrast-enhanced 1.5 T MRI. Precontrast axial T1-weighted imaging was used to select five slices for the dynamic study. Subsequently, a T1-weighted FLASH sequence was used for the dynamic contrast study (0.2 ml Gd/kg x body weight). Contrast agent application and the FLASH sequence were started simultaneously. Ten acquisitions of 10 seconds' scan time each were performed (total acquisition time 1:40 minutes). Signal intensity versus time (SIvT) curves was obtained for all tumors. After correlation of the categorized SIvT curves, these were compared with histopathology. Finally, all MRIs together with the tumor specific SIvT curves were re-read and correlated with histopathologic diagnosis. All reading sessions were done by three experienced radiologists. RESULTS: Four characteristic intensity-time curves were observed: pleomorphic adenoma showed a gradual increase in signal intensity, followed by a plateau phase on a low intensity level. Cysts showed a vacillating course at a low signal intensity level. Adenolymphomas as well as carcinomas showed a rapid increase in signal intensity followed by a plateau phase. Statistic significance was found for the time-to-peak values for adenolymphomas and pleomorphic adenomas and for the maximum peak signal intensity values for carcinomas. Together with other morphologic MRI criteria (contrast enhancement, border characteristics) and clinical features, a differentiation between adenolymphoma and carcinoma was possible. CONCLUSIONS: With additional dynamic contrast-enhanced MRI, a more reliable differentiation between common parotid tumors is possible before surgery.
Authors:
Sedat Alibek; Johannes Zenk; Alessandro Bozzato; Michael Lell; Markus Grunewald; Katharina Anders; Christina Rabe; Heinrich Iro; Werner Bautz; Holger Greess
Publication Detail:
Type:  Clinical Trial; Journal Article; Research Support, Non-U.S. Gov't    
Journal Detail:
Title:  Academic radiology     Volume:  14     ISSN:  1076-6332     ISO Abbreviation:  Acad Radiol     Publication Date:  2007 Jun 
Date Detail:
Created Date:  2007-05-15     Completed Date:  2007-08-23     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  9440159     Medline TA:  Acad Radiol     Country:  United States    
Other Details:
Languages:  eng     Pagination:  701-10     Citation Subset:  IM    
Affiliation:
Institute of Radiology, University of Erlangen/Nuremberg, Maximiliansplatz 1 - 91054 Erlangen, Germany. sedat.alibek@idr.imed.uni-erlangen.de
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adenolymphoma / diagnosis*,  surgery
Adenoma, Pleomorphic / diagnosis*,  surgery
Adolescent
Adult
Aged
Aged, 80 and over
Carcinoma / diagnosis*,  surgery
Child
Contrast Media / administration & dosage
Diagnosis, Differential
Female
Gadolinium / diagnostic use
Humans
Image Enhancement / methods
Magnetic Resonance Imaging / methods*
Male
Middle Aged
Observer Variation
Parotid Gland / pathology*,  surgery
Parotid Neoplasms / diagnosis*,  surgery
Predictive Value of Tests
Prospective Studies
Sensitivity and Specificity
Chemical
Reg. No./Substance:
0/Contrast Media; 7440-54-2/Gadolinium

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Evidence of subcortical and cortical aging of the acoustic pathway: a diffusion tensor imaging (DTI)...
Next Document:  Satisfaction of search in multitrauma patients: severity of detected fractures.